Orchestra BioMed Holdings, Inc. (OBIO) Q1 2024 Earnings
OBIO·Reported May 13, 2024·Before market open
Orchestra BioMed Holdings, Inc. reported Q1 2024 revenue of $620.0K, missed analyst consensus of $950.0K by $330.0K. Diluted EPS came in at $-0.38, beat the $-0.40 consensus by $0.02.
Revenue
$620.0Kmissed by $330.0K
Consensus: $950.0KDiluted EPS
$-0.38beat by $0.02
Consensus: $-0.40
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Orchestra BioMed Holdings, Inc.'s Q1 2024 earnings report.
Orchestra BioMed Holdings, Inc. (OBIO) reported Q1 2024 earnings on May 13, 2024 before market open.
Orchestra BioMed Holdings, Inc. reported revenue of $620.0K and diluted EPS of $-0.38 for Q1 2024.
Revenue missed the consensus estimate of $950.0K by $330.0K. EPS beat the consensus estimate of $-0.40 by $0.02.
You can read the 10-Q periodic report (0001558370-24-007978) directly on SEC EDGAR. The filing index links above go to sec.gov.